DR
Dylan Reid
Partner at Zetta
DR
Dylan Reid
Partner at Zetta
New York, New York
Overview
Work Experience
Partner
2018 - Current
Investing in AI-native sciences, services and software. Early-backer and believer in Faro, VideaHealth, Nabla Bio, Noetik and more.
Investor / Observer
2022
Using Foundation Models and Spatial Biology to Discover Targeted Immunotherapies.
Investor / Observer
2021
Using Protein Language Models and Massively Multiplex Screening to Design Impossible Antibodies.
Investor / Director
2019
Using LLMs to Design Better, Faster, More Efficient Clinical Trials.
Investor / Director
2022
Using AI and Combinatorial Chemistry to Design Non-Viral Delivery Vehicles for mRNA
Investor
2022
Software for closed-loop science. Small personal investor, big believer.
Investor
2017
AI-first industrial inspection. Pre-seed investor.
Investor
2018
Semi-autonomous forklifts. Pre-seed investor (first check).
Investor
2018
Closed-loop construction. Pre-seed investor (Pre-YC).
Investor
2018
Lab-grown fat, climate-friendly bacon. Seed investor.
Education
Bachelor’s Degree
2008 - 2012